These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2919414)

  • 21. Leukotriene synthesis by human gastrointestinal tissues.
    Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
    Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene and anti-IgE induced contractions of human isolated trachea: studies with leukotriene receptor antagonists and a novel 5-lipoxygenase inhibitor.
    Jones TR; Charette L; Denis D
    Can J Physiol Pharmacol; 1988 Jun; 66(6):762-8. PubMed ID: 2844372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipoxygenase reaction and leukotrienes].
    Shimizu T
    Seikagaku; 1986 Feb; 58(2):92-117. PubMed ID: 3011926
    [No Abstract]   [Full Text] [Related]  

  • 24. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
    Rokach J; Young RN
    Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345
    [No Abstract]   [Full Text] [Related]  

  • 25. The alterations of leukotriene C4 and prostaglandin E2 levels following different ischemic periods in rat brain tissue.
    Aktan S; Aykut C; Oktay S; Yegen B; Keles E; Aykaç I; Ercan S
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):67-71. PubMed ID: 2011613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis].
    Lototskaia LS; Naĭdenova IIu; Il'iasheva LM; Poda GI; Kornilov AI
    Farmakol Toksikol; 1989; 52(2):59-62. PubMed ID: 2501105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.
    Moroney MA; Alcaraz MJ; Forder RA; Carey F; Hoult JR
    J Pharm Pharmacol; 1988 Nov; 40(11):787-92. PubMed ID: 2907559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
    Tennant CM; Seale JP; Temple DM
    J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of alveolar macrophage 5-lipoxygenase metabolism by auranofin.
    Peters-Golden M; Shelly C
    Biochem Pharmacol; 1989 May; 38(10):1589-95. PubMed ID: 2499339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
    Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
    J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis.
    Hammond ML; Kopka IE; Zambias RA; Caldwell CG; Boger J; Baker F; Bach T; Luell S; MacIntyre DE
    J Med Chem; 1989 May; 32(5):1006-20. PubMed ID: 2709371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():507-10. PubMed ID: 2546393
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of arachidonic acid metabolites in local and systemic inflammatory processes.
    Austen KF
    Drugs; 1987; 33 Suppl 1():10-7. PubMed ID: 3036459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
    Jolly SR; Travis J; Van Inwegen RG
    Pharmacology; 1989; 38(6):352-62. PubMed ID: 2813496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotrienes in the rat central nervous system.
    Lindgren JA; Hökfelt T; Dahlén SE; Patrono C; Samuelsson B
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6212-6. PubMed ID: 6091141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
    Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma.
    Vigano T; Toia A; Crivellari MT; Galli G; Mezzetti M; Folco GC
    Eicosanoids; 1988; 1(2):73-7. PubMed ID: 3152489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachidonate 5-lipoxygenase and its new inhibitors.
    Yamamoto S; Yoshimoto T; Furukawa M; Horie T; Watanabe-Kohno S
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):349-52. PubMed ID: 6432877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of allergen-induced bronchoconstriction in hyperreactive rats as a model for testing 5-lipoxygenase inhibitors and leukotriene D4 receptor antagonists.
    Piechuta H; Ford-Hutchinson AW; Letts LG
    Agents Actions; 1987 Oct; 22(1-2):69-74. PubMed ID: 2825489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of isolated human bronchi contraction and biosynthesis of cysteinyl leukotrienes using a direct 5-lipoxygenase inhibitor.
    Bolla M; Caruso P; Giossi M; Folco G; Civelli M; Sala A
    Biochem Pharmacol; 1997 Aug; 54(4):437-42. PubMed ID: 9313769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.